表紙
市場調查報告書

電子藥物遞輸系統的全球市場:市場機會分析及未來預測

Global Electronic Drug Delivery Systems Market Size study, by Type (Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pens & Electronic Inhalers), Indication & Regional Forecasts 2019-2026

出版商 Bizwit Research & Consulting LLP 商品編碼 918544
出版日期 內容資訊 英文
商品交期: 2-3個工作天內
價格
電子藥物遞輸系統的全球市場:市場機會分析及未來預測 Global Electronic Drug Delivery Systems Market Size study, by Type (Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pens & Electronic Inhalers), Indication & Regional Forecasts 2019-2026
出版日期: 2019年04月01日內容資訊: 英文
簡介

本報告提供電子藥物遞輸系統的世界市場調查,市場概要,各類型,各地區的市場趨勢,市場規模的變化與預測,市場促進、阻礙因素以及市場機會分析,競爭情形,主要企業的簡介等全面性資訊。

目錄

第1章 摘要整理

  • 市場概述
  • 全球的及市場區隔的市場預測,2017年-2026年(10億美元)
    • 各地區
    • 各類型
    • 各適應症
  • 主要的趨勢
  • 預測方法
  • 調查的前提條件

第2章 市場定義和範圍

  • 調查的目的
  • 市場定義和範圍
    • 調查範圍
    • 產業的演進
  • 調查期間
  • 貨幣換算比率

第3章 市場動態

  • 市場影響分析(2018-2026)
    • 成長要素
    • 市場課題
    • 市場機會

第4章 市場產業分析

  • 五力分析模型
    • 供應商談判力
    • 買方議價能力
    • 新加入廠商的威脅
    • 替代品的威脅
    • 競爭企業
    • 對五力分析模型的未來方法
  • PEST分析
    • 政治方案
    • 經濟方案
    • 社會方案
    • 技術方案
  • 投資採用模式
  • 分析師的推薦和結論

第5章 電子藥物遞輸系統市場:各類型

  • 市場概述
  • 類型,性能 - 潛在性分析
  • 市場估計值及預測,2016-2026年(10億美元)
  • 子區隔分析
    • 電子穿戴式輸液幫浦
    • 電子自動注射器
    • 電子注射筆
    • 電子吸入配料

第6章 電子藥物遞輸系統市場:各適應症

  • 市場概述
  • 適應症,性能 - 潛在性分析
  • 市場估計值及預測,2016-2026年(10億美元)
  • 子區隔分析
    • 糖尿病
    • 多發性硬化症
    • 心血管疾病
    • 氣喘 & COPD
    • 其他

第7章 電子藥物遞輸系統市場:各地區

  • 地區市場概述
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 其他
  • 中南美
    • 巴西
    • 墨西哥
  • 其他

第8章 競爭情形

  • 首位市場策略
  • 企業簡介
    • Merck Group
    • United Therapeutics Corporation
    • Medtronic PLC
    • Bayer AG
    • Insulet Corporation
    • Novo Nordisk
    • Companion Medical
    • F.Hoffmann-La Roche, Ltd.
    • Amgen, Inc.
    • Astrazeneca PLC

第9章 調查方法

  • 調查方法
    • 資料探勘
    • 分析
    • 市場預測
    • 檢驗
    • 出版
  • 調查屬性
  • 調查的前提條件
目錄

Title:
Global Electronic Drug Delivery Systems Market Size study, by Type (Electronic Wearable Infusion Pumps, Electronic Autoinjectors, Electronic Injection Pens and Electronic Inhalers), By Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD and Other Indications) and Regional Forecasts 2019-2026.

Global Electronic Drug Delivery Systems Market is valued approximately at USD 7.20 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.70% over the forecast period 2019-2026. An electronic drug delivery system can deliver one drug or several different types of drugs to a specific site in gastrointestinal tract (GIT), where it may normally be difficult to do, can also be used for patient monitoring. Further, growing prevalence of target disease, advancements in technologies & designs of electronic drug delivery systems along with favorable reimbursement scenario are some major factors driving the growth of the market. For Instance: as per the Centers for Disease Control and Prevention in 2017, a total of 9,105 tuberculosis cases were reported in United States. As a result, the demand and adoption of electronic drug delivery systems would increase. However, preference for alternative drug delivery modes and the possibility of errors is beholding the confidence of users towards purchase of electronic drug delivery systems globally.

The regional analysis of global Electronic Drug Delivery Systems Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the favorable reimbursement scenario, and approvals, rising prevalence of target diseases, and launches of innovative electronic drug delivery systems. Whereas, Asia-Pacific is anticipated to emerge as the fastest growing region during the forecast period 2019- 2026.

Major market player included in this report are:

  • Merck Group
  • United Therapeutics Corporation
  • Medtronic PLC
  • Bayer AG
  • Insulet Corporation
  • Novo Nordisk
  • Companion Medical
  • F.Hoffmann-La Roche, Ltd.
  • Amgen, Inc.
  • Astrazeneca PLC

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Electronic Wearable Infusion Pumps
  • Electronic Autoinjectors
  • Electronic Injection Pens
  • Electronic Inhalers

By Indication:

  • Diabetes
  • Multiple Sclerosis
  • Cardiovascular Disease
  • Asthma & COPD
  • Other Indications

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Mexico
  • Rest of the World

Furthermore, years considered for the study are as follows:

  • Historical year - 2016-,2017
  • Base year - 2018
  • Forecast period - 2019 to 2026

Target Audience of the Global Electronic Drug Delivery Systems Market in Market Study:

  • Key Consulting Companies & Advisors
  • Large, medium-sized, and small enterprises
  • Venture capitalists
  • Value-Added Resellers (VARs)
  • Third-party knowledge providers
  • Investment bankers
  • Investors

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
    • 1.2.1. Electronic Drug Delivery Systems Market, by Region, 2017-2026 (USD Billion)
    • 1.2.2. Electronic Drug Delivery Systems Market, by Type, 2017-2026 (USD Billion)
    • 1.2.3. Electronic Drug Delivery Systems Market, by Indication, 2017-2026 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Electronic Drug Delivery Systems Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Electronic Drug Delivery Systems Market Dynamics

  • 3.1. Electronic Drug Delivery Systems Market Impact Analysis (2018-2026)
    • 3.1.1. Market Drivers
    • 3.1.2. Market Challenges
    • 3.1.3. Market Opportunities

Chapter 4. Global Electronic Drug Delivery Systems Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2016-2026)
  • 4.2. PEST Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
  • 4.3. Investment Adoption Model
  • 4.4. Analyst Recommendation & Conclusion

Chapter 5. Global Electronic Drug Delivery Systems Market, by Type

  • 5.1. Market Snapshot
  • 5.2. Global Electronic Drug Delivery Systems Market by Type, Performance - Potential Analysis
  • 5.3. Global Electronic Drug Delivery Systems Market Estimates & Forecasts by Type 2016-2026 (USD Billion)
  • 5.4. Electronic Drug Delivery Systems Market, Sub Segment Analysis
    • 5.4.1. Electronic Wearable Infusion Pumps
    • 5.4.2. Electronic Autoinjectors
    • 5.4.3. Electronic Injection Pens
    • 5.4.4. Electronic Inhalers

Chapter 6. Global Electronic Drug Delivery Systems Market, By Indication

  • 6.1. Market Snapshot
  • 6.2. Global Electronic Drug Delivery Systems Market by Application, Performance - Potential Analysis
  • 6.3. Global Electronic Drug Delivery Systems Market Estimates & Forecasts by Indication 2016-2026 (USD Billion)
  • 6.4. Electronic Drug Delivery Systems Market, Sub Segment Analysis
    • 6.4.1. Diabetes
    • 6.4.2. Multiple Sclerosis
    • 6.4.3. Cardiovascular Disease
    • 6.4.4. Asthma & COPD
    • 6.4.5. Other Indications

Chapter 7. Global Electronic Drug Delivery Systems Market, Regional Analysis

  • 7.1. Electronic Drug Delivery Systems Market, Regional Market Snapshot
  • 7.2. North America Electronic Drug Delivery Systems Market
    • 7.2.1. U.S. Electronic Drug Delivery Systems Market
      • 7.2.1.1. Type breakdown estimates & forecasts, 2016-2026
      • 7.2.1.2. Indication breakdown estimates & forecasts, 2016-2026
    • 7.2.2. Canada Electronic Drug Delivery Systems Market
  • 7.3. Europe Electronic Drug Delivery Systems Market Snapshot
    • 7.3.1. U.K. Electronic Drug Delivery Systems Market
    • 7.3.2. Rest of Europe Electronic Drug Delivery Systems Market
  • 7.4. Asia-Pacific Electronic Drug Delivery Systems Market Snapshot
    • 7.4.1. China Electronic Drug Delivery Systems Market
    • 7.4.2. India Electronic Drug Delivery Systems Market
    • 7.4.3. Japan Electronic Drug Delivery Systems Market
    • 7.4.4. Rest of Asia Pacific Electronic Drug Delivery Systems Market
  • 7.5. Latin America Electronic Drug Delivery Systems Market Snapshot
    • 7.5.1. Brazil Electronic Drug Delivery Systems Market
    • 7.5.2. Mexico Electronic Drug Delivery Systems Market
  • 7.6. Rest of The World Electronic Drug Delivery Systems Market

Chapter 8. Competitive Intelligence

  • 8.1. Top Market Strategies
  • 8.2. Company Profiles
    • 8.2.1. Merck Group
      • 8.2.1.1. Key Information
      • 8.2.1.2. Overview
      • 8.2.1.3. Financial (Subject to Data Availability)
      • 8.2.1.4. Type Summary
      • 8.2.1.5. Recent Developments
    • 8.2.2. United Therapeutics Corporation
    • 8.2.3. Medtronic PLC
    • 8.2.4. Bayer AG
    • 8.2.5. Insulet Corporation
    • 8.2.6. Novo Nordisk
    • 8.2.7. Companion Medical
    • 8.2.8. F.Hoffmann-La Roche, Ltd.
    • 8.2.9. Amgen, Inc.
    • 8.2.10. Astrazeneca PLC

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
  • 9.3. Research Assumption

List of Tables

  • TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET
  • TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET
  • TABLE 3. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, REPORT SCOPE
  • TABLE 4. YEARS CONSIDERED FOR THE STUDY
  • TABLE 5. EXCHANGE RATES CONSIDERED
  • TABLE 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
  • TABLE 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY TYPE 2016-2026 (USD BILLION)
  • TABLE 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY INDICATION 2016-2026 (USD BILLION)
  • TABLE 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 19. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 20. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 21. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 22. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 23. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 24. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 25. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 26. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 27. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 28. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 29. U.S. ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 30. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 31. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 32. CANADA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 33. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 34. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 35. UK ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 36. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 37. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 38. GERMANY ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 39. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 40. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 41. ROE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 42. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 43. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 44. CHINA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 45. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 46. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 47. INDIA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 48. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 49. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 50. JAPAN ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 51. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 52. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 53. ROAPAC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 54. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 55. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 56. BRAZIL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 57. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 58. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 59. MEXICO ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 60. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 61. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 62. ROLA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 63. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
  • TABLE 64. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
  • TABLE 65. ROW ELECTRONIC DRUG DELIVERY SYSTEMS MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

List of Figures

  • FIG 1. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, RESEARCH METHODOLOGY
  • FIG 2. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, MARKET ESTIMATION TECHNIQUES
  • FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
  • FIG 4. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, KEY TRENDS 2018
  • FIG 5. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, GROWTH PROSPECTS 2019-2026
  • FIG 6. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, PORTERS 5 FORCE MODEL
  • FIG 7. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, PEST ANALYSIS
  • FIG 8. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, VALUE CHAIN ANALYSIS
  • FIG 9. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 10. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 11. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 12. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 13. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 14. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 15. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 16. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 17. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
  • FIG 18. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, REGIONAL SNAPSHOT 2016 & 2026
  • FIG 19. NORTH AMERICA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 20. EUROPE ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 21. ASIA PACIFIC ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 22. LATIN AMERICA ELECTRONIC DRUG DELIVERY SYSTEMS MARKET 2016 & 2026 (USD BILLION)
  • FIG 23. GLOBAL ELECTRONIC DRUG DELIVERY SYSTEMS MARKET, COMPANY MARKET SHARE ANALYSIS (2018)